Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 3,553 ALMS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | ALUMIS INC. (ALMS) | Grant/Award | 3,553 | n/a |
| Jun 12, 2026 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 5,700 | n/a |
| Jun 4, 2026 | Xenon Pharmaceuticals Inc. (XENE) | Exercise/Conversion | 2,645 | n/a |
| Dec 10, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Tender of Shares | 8,818 | n/a |
| Aug 1, 2025 | ALUMIS INC. (ALMS) | Grant/Award | 49,800 | n/a |
| Jun 20, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 10,450 | n/a |
| Jun 12, 2025 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 13,300 | n/a |
| Jun 6, 2025 | Xenon Pharmaceuticals Inc. (XENE) | Grant/Award | 17,012 | n/a |
| May 23, 2025 | ALUMIS INC. (ALMS) | Grant/Award | 7,064 | n/a |
| Jul 1, 2024 | ALUMIS INC. (ALMS) | Grant/Award | 38,000 | n/a |